Efficacy and safety of bosutinib vs imatinib in Indian and non-Indian patients with newly diagnosed chronic phase chronic myeloid leukemia: Subgroup analysis from the BELA trial

H. Malhotra, A. Maru, N. Khattry, M. V. Ramanan, E. Leip, R. J. Crescenzo, C. Gambacorti-Passerini, J. E. Cortes

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)viii367-viii368
JournalAnnals of oncology : official journal of the European Society for Medical Oncology
StatePublished - Oct 1 2018
Externally publishedYes

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this